FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.05-5029fje.
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-5029fjev1
20/12/2159    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, H.
Right arrow Articles by Ylä-Herttuala, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, H.
Right arrow Articles by Ylä-Herttuala, S.
(The FASEB Journal. 2006;20:2159-2161.)
© 2006 FASEB

VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-{kappa}B, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits

Himadri Roy*, Shalini Bhardwaj*, Mohan Babu*, Ilze Kokina*, Sanna Uotila*, Tiia Ahtialansaari*, Teemu Laitinen§, Juhana Hakumaki§, Markku Laakso{dagger}, Karl-Heinz Herzig*,{dagger} and Seppo Ylä-Herttuala*,{dagger},{ddagger},1


* Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Finland;

{dagger} Department of Medicine, University of Kuopio, Finland;

{ddagger} Gene Therapy Unit, Kuopio, University Hospital, Finland; and

§ Department of Biomedical NMR, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, Finland

1Correspondence: Department of Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: seppo.ylaherttuala{at}uku.fi

SPECIFIC AIMS

The objectives of this study were to 1) to develop a diabetic hyperlipidemic animal model that would allow studies of the combined effects of these risk factors on atherogenesis and 2) investigate the effects of these risk factors on the expression of vascular endothelial growth factor (VEGF)-A, VEGF-D, VEGFR-1, VEGFR-2, and angiogenesis in atherosclerotic lesions.

PRINCIPAL FINDINGS

1. Accelerated atherogenesis in diabetic rabbits
Alloxan was used to induce diabetes in male Watanabe heritable hyperlipidemic (WHHL) rabbits that were sacrificed 2 and 6 months after the induction of diabetes. Nondiabetic WHHL rabbits served as controls. Blood glucose (Glc), serum-free fatty acids (FFA), and serum triglyceride levels were significantly higher in diabetic rabbits. A significant increase (P<0.05) in intramyocellular lipids (IMCL), as determined by 1H-NMR spectroscopy, was observed in the diabetic rabbits. Atherosclerosis was significantly increased in the 2 month (P<0.01) and 6 month (P<0.001) diabetic groups (see online manuscript) along with a significant (P<0.001) increase in the immunostained area positive for macrophages in the diabetic rabbits at 6 months (Fig. 1 A).


Figure 1
View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. Immunohistochemical analysis of atherosclerotic lesions in diabetic rabbits. A) RAM-11 immunostaining for macrophages was significantly increased in the 6 month subgroup. B) HHF-35 immunostaining for smooth muscle cells in diabetic and control rabbits was similar. C) Areas of RAGE and D) NF-{kappa}B p65 immunostainings were significantly increased in diabetic rabbits. E) VEGF-A staining was significantly increased in diabetic rabbits at both time points whereas F) VEGF-D staining was increased only at the 6 month time point. G) A significant increase in VEGFR-2 and (H) VEGFR-1 immunostaining was present at the 6 month time point in diabetic rabbits. I) The number of capillaries in the atherosclerotic lesions of the diabetic rabbits tended to be increased compared with controls, but the difference was not statistically significant. *P < 0.05; **P < 0.01; ***P < 0.001.

2. Increased RAGE and NF-{kappa}B p65 expression in atherosclerotic lesions of diabetic rabbits
There was a significant increase in RAGE staining in both the 2 and the 6 month diabetic rabbits. RAGE localized predominantly in the endothelial cells, subendothelial region, macrophages, and foam cells (Fig. 1C ). Immunohistochemical staining for NF-{kappa}B p65 was significantly higher in both the 2 and the 6 month diabetic rabbits (Fig. 1D ). NF-{kappa}B p65 staining was most prominent in macrophages, but positive immunostaining was also observed in some endothelial cells and smooth muscle cells.

3. Angiogenic growth factors and angiogenesis in atherosclerotic plaques
Real-time quantitative RT-polymerase chain reaction (RT-PCR) from aortas showed that VEGF-A165 mRNA expression was significantly increased (P<0.05) in the diabetic rabbits (see online manuscript). VEGF-A121 mRNA expression levels were comparable in the aortas of diabetic and control animals. VEGF-A immunostaining was significantly increased in both the 2 and the 6 month diabetic subgroups (Fig. 1E ). VEGF-A immunostaining was localized mostly in lesion macrophages and smooth muscle cells.

VEGF-D immunostaining tended to be increased in the 2 month diabetic group, but the difference with the controls was not significant. In the 6 month diabetic group, however, a significant increase was found (Fig. 1F ). VEGF-D was detected in macrophages, smooth muscle cells, and endothelial cells.

VEGFR-1 immunostaining was seen in endothelial cells, macrophages, and some smooth muscle cells
VEGFR-2 immunostaining was detected in smooth muscle cells and in some endothelial cells. VEGFR-1 and VEGFR-2 stainings in the atherosclerotic plaques were significantly increased in the 6 month diabetic rabbits (Fig. 1G, H ). VEGFR-2 mRNA levels were also significantly increased in the aortas of the diabetic rabbits (see online manuscript).

Positive cluster of differentiation-31 (CD-31) immunostaining was localized in the endothelium. Some medium-sized blood vessels were also seen in the aortic wall in the 6 month diabetic rabbits. The number of vessels in the atherosclerotic lesions of the diabetic rabbits tended to be higher than the controls, but the difference did not reach statistical significance (Fig 1I ).

CONCLUSIONS AND SIGNIFICANCE

Alloxan-induced diabetes in WHHL rabbits significantly increased serum cholesterol, triglyceride, and FFA levels. There was also a significant increase in IMCL content and atherosclerosis in these animals. Thus, induction of diabetes in WHHL rabbits produced an animal model that had increased FFA, insulin resistance, hyperglycemia, and dyslipidemia. We used this animal model to evaluate the effects of diabetes on atherogenesis and plaque angiogenesis. This study demonstrated a significant increase in the presence of VEGF-A, VEGF-D, VEGF receptor-1, and VEGF receptor-2 and a trend toward increased vascularization in the atherosclerotic lesions of the diabetic WHHL rabbits. The results also show a significant increase in VEGF-A165 but not VEGF-A121 mRNA expression in the diabetic rabbits. This suggests that diabetes has a selective effect on the expression of different VEGF-A isoforms. An increased presence of NF-{kappa}B p65 and RAGE was also found in diabetic atherosclerotic lesions. This indicates that diabetes increases proinflammatory responses in the atherosclerotic lesions. Induction of VEGF-A and VEGF-D through a pathway involving RAGE and NF-{kappa}B/activating protein-1 could explain the increased expression of VEGFs in the atherosclerotic lesions of the diabetic rabbits. In conclusion, we generated a model of diabetic macrovascular disease. Our results suggest that diabetes accelerates atherogenesis, up-regulates VEGF-A, VEGF-D, VEGF receptor-1 expression and VEGF receptor-2 expression and increases NF-{kappa}B, RAGE, and proinflammatory responses in atherosclerotic leisons.


Figure 2
View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Accelerated atherosclerosis in WHHL rabbit model of diabetes and dyslipidemia. It has been hypothesized that in diabetes there is an induction of VEGF-A and VEGF-D expression through a pathway involving RAGE and NF-{kappa}B that enhances inflammation and plaque vascularization. Macrophages also contribute to accelerated atherosclerosis in diabetic rabbits.

FOOTNOTES

To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.05-5029fje




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. D. Miller, Y. Chu, R. M. Brooks, W. E. Richenbacher, R. Pena-Silva, and D. D. Heistad
Dysregulation of Antioxidant Mechanisms Contributes to Increased Oxidative Stress in Calcific Aortic Valvular Stenosis in Humans
J. Am. Coll. Cardiol., September 2, 2008; 52(10): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Addabbo, F. Mallamaci, D. Leonardis, R. Tripepi, G. Tripepi, M. S. Goligorsky, and C. Zoccali
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3521 - 3526.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. E. Heinonen, P. Leppanen, I. Kholova, H. Lumivuori, S.-K. Hakkinen, F. Bosch, M. Laakso, and S. Yla-Herttuala
Increased Atherosclerotic Lesion Calcification in a Novel Mouse Model Combining Insulin Resistance, Hyperglycemia, and Hypercholesterolemia
Circ. Res., November 9, 2007; 101(10): 1058 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Kivela, M. Silvennoinen, M. Lehti, H. Kainulainen, and V. Vihko
Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2573 - H2579.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L. M Agius
Complicated atheromatous plaque as integral atherogenesis
J. Clin. Pathol., June 1, 2007; 60(6): 589 - 592.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-5029fjev1
20/12/2159    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, H.
Right arrow Articles by Ylä-Herttuala, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, H.
Right arrow Articles by Ylä-Herttuala, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.